ONECUT2 is a novel target for treatment of castration-resistant prostate cancer

Authors

Tejashree Joglekar, School of Medicine and Health Sciences
Jianqing Lin, School of Medicine and Health Sciences
Maho Shibata, School of Medicine and Health Sciences

Document Type

Editorial

Publication Date

2-1-2020

Journal

Expert Opinion on Therapeutic Targets

Volume

24

Issue

2

DOI

10.1080/14728222.2020.1723080

Keywords

AR-independent prostate cancer; castration-resistant prostate cancer; neuroendocrine prostate cancer; ONECUT2; prostate cancer

APA Citation

Joglekar, T., Lin, J., & Shibata, M. (2020). ONECUT2 is a novel target for treatment of castration-resistant prostate cancer. Expert Opinion on Therapeutic Targets, 24 (2). http://dx.doi.org/10.1080/14728222.2020.1723080